Work

Impaired Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease

Year: 2014

Type: article

Source: Journal of the American College of Cardiology

DOI: 10.1016/j.jacc.2014.06.1170

Authors: Dominick J. Angiolillo, Joseph A. Jakubowski, José Luis Ferreiro, Antonio Tello-Montoliu, Fabiana Rollini, Francesco Franchi, Masafumi Ueno, Andrew Darlington, Bhaloo Desai, Brian A. Moser, Atsuhiro Sugidachi, Luis A. Guzman, Theodore A. Bass

Institutions: University of Florida, University of Florida Health Science Center, Eli Lilly (United States), Daiichi-Sankyo (Japan)

Language: English

Topic: Antiplatelet Therapy and Cardiovascular Diseases

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, Sanofi, Gilead Sciences, Sunovion, Medicines Company, St. Jude Medical, Abbott Vascular, Daiichi Sankyo Europe

OpenAlex ID: W1964067479

FWCI: 13.6

Cites: 49

Cited by: 182

Related to: 10